Advancing Hemophilia Care Through Global Research – WFH
World Federation of Hemophilia shared a post on LinkedIn:
“Turning data into action for people with hemophilia and other bleeding disorders.
On october 31 and november 1, NMO representatives and healthcare professionals from across Central America, South America, and the Caribbean gathered in the DominicanRepublic. Joined by Cesar Garrido, President, WFH, they took part in a World Bleeding Disorders Registry workshop focused on research and advocacy.
Through practical group activities, participants explored how to develop research proposals, use WBDR data to support research initiatives, and translate evidence into effective advocacy and public policy across the region.
Thank you to our Visionary Partner, Hemophilia of Georgia, and our Collaborating Partners, Pfizer and Roche, for supporting the workshop.
Additional thanks to Novo Nordisk.”
More posts about WFH on Hemostasis Today.
-
Nov 4, 2026, 14:12Jean-Jacques Kiladjian: From JAK Inhibitor-Associated Skin Cancers to Laboratory Discovery
-
Nov 4, 2026, 13:59Rita Li: ASH 2026 Abstract Achievement Award for Gut Microbiome Research
-
Nov 4, 2026, 13:38Omid Seidizadeh: Improving Access to von Willebrand Disease Diagnosis and Treatment Across Europe
-
Nov 4, 2026, 13:38Fiona Robinson: NBDF Webinar Explores the Practical Challenges of Hemophilia Gene Therapy
-
Nov 4, 2026, 13:33Reza Shojaei: AI-Driven Innovation in Blood and Plasma Services
-
Nov 4, 2026, 13:21Adela Perolla: Bringing International Hematology Expertise to the Next Generation of Physicians
-
Nov 4, 2026, 13:06Teclistamab Shows Promise in Refractory Autoantibody-Mediated Coagulation Disorders – JTH
-
Nov 4, 2026, 12:53Douglas Tavares: Why Patient Blood Management Remains Underused Despite Decades of Evidence
-
Nov 4, 2026, 12:40Jasem Albasri: Innovation and Progress in Laboratory Medicine